Patent Attorney, Melbourne | BA, BSc (Hons), PhD, MIP Law
Direct +61 3 9288 1213
As a Patent Attorney with FPA Patent Attorneys, Sarah specialises in IP matters for the pharmaceutical and life sciences sectors. Sarah’s current practice involves prosecuting Australian and foreign patent applications and drafting patent specifications. She also assists in the preparation of detailed freedom to operate and validity opinions as well as assisting in patent oppositions.
Prior to joining the firm in 2011, Sarah worked for three years as a postdoctoral research officer at the Baker IDI Heart and Diabetes Institute. There, her research involved the characterisation of proteins that modulate the activity of the sympathetic nervous system and in particular, the regulation of blood pressure.
Sarah was awarded a PhD in Biochemistry and Molecular Biology in 2007. Her PhD studies, undertaken at the Bio21 Institute, focused on elucidating the evolution of the structure and function of transthyretin-like proteins.
Sarah has several publications in peer-reviewed scientific journals including Molecular Psychiatry, The Journal of Molecular Biology and PLoS One. Articles can be viewed at the US National Library of Medicine, National Institutes of Health, National Center for Biotechnology Information (PubMed) and PLoS One. She has also presented at a number of local and international conferences including the annual meetings of The European Society of Hypertension and The Society for Molecular Biology and Evolution.
While completing the Master of Intellectual Property Law at the University of Melbourne, Sarah was awarded the Frank Pinkerton Scholarship for the best result in the subject Fundamentals of Patent Drafting.
Areas of expertise
• Molecular and Cell Biology
• Agribusiness and Agrochemicals
• Plant Breeders Rights
• Bachelor of Arts (Criminology and History and Philosophy of Science), University of Melbourne
• Bachelor of Science (Biochemistry and Molecular Biology) (Hons), University of Melbourne
• Doctor of Philosophy (Faculty of Medicine), University of Melbourne and The Bio21 Institute
• Master of Intellectual Property Law, University of Melbourne
Latest articles authored by Sarah Hennebry- When inventive steps become routine...greater hurdles for applicants with claims directed to antibodies - High Court of Australia determines isolated BRCA1 gene not patentable in Australia - Trans-Pacific Partnership agreement on term of data exclusivity for biological pharmaceuticals, not patent term
View all articles authored by Sarah Hennebry